Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Centaurus Biopharma Co., Ltd.

Lianyungang Runzhong Pharmaceutical Co., Ltd.

Shang Wang

Zhilin Chen

Yi Xu

Ping Dong

Xinlu Li

Xifeng Lu

Min Li

Shan Zhou

Lei Liu

Lihui Dong

Haishan Zang

Yuanyuan Sun

Jianghui Jing

Laicun Li

Peng Sun

Jing Gao

Xiandong Zhao

A solid pharmaceutical composition comprising a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine, a preparation method therefor, and an medical application thereof. The solid pharmaceutical composition has excellent stability and dissolution properties.

Solid pharmaceutical composition comprising TLR7 agonist

A solid pharmaceutical composition containing a 1,3,5-triazine derivative or a pharmaceutically acceptable salt thereof and a preparation method therefor. In particular, involved are a solid pharmaceutical composition containing 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazine-2-amine or a pharmaceutically acceptable salt thereof and a preparation method therefor. The solid pharmaceutical composition has a good stability, a fast dissolution rate and a high bioavailability, and is suitable for clinical production and use.

Solid pharmaceutical composition containing 1,3,5-triazine derivative or salt thereof

Growing community of inventors

Lianyungang, China

Shang Wang